GENE ONLINE|News &
Opinion
Blog

2020-07-19| Asia-PacificR&D

A Rising Hope in Therapeutics — From Precision Medicine to Advanced Therapies

by GeneOnline
Share To

With a better understanding of biological pathways, steady advances in bio-molecular genetic engineering have been made, driving modern drug development to new heights. Such therapeutic developments include cancer Immunotherapy, cell therapy, gene therapy, CRISPR editing, and RNA therapeutics. Besides serving us in battles against cancer and rare diseases, these breakthroughs have also shown potential as new therapeutics against the current pandemic.

This year at BIO Asia–Taiwan we’ve invited recognized professionals in the field to share their views on the new frontier of bio-therapeutics. In the session “From Precision Medicine to Precision Health”, opinion leaders will address today’s new challenges, how to best utilize new technologies and manage increasingly large volumes of patient data—all to deliver the right medicine to the right patient.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Repairing Genetic Mutations in Neurological Diseases with RNA Targeting Strategy
2022-11-25
Hemgenix Marks Most Expensive Treatment Ever and First Gene Therapy for Hemophilia B
2022-11-22
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
LATEST
Axsome’s AXS-05 Achieves Endpoints In Alzheimer’s Agitation Trial
2022-11-29
Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
2022-11-28
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
2022-11-28
Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan
2022-11-28
GenFleet Therapeutics to Present Data from Phase I Trial of GFH009 Monotherapy at the 2022 Annual Meeting of American Society of Hematology (ASH)
2022-11-28
Everest’s Renal Drug Gets Placed On Fast Track For Approval In Taiwan And Korea
2022-11-28
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
EVENT
2022-12-01
BIOCHINA 2022
Online
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!